Who owns Adaptimmune Therapeutics?
- Ticker: ADAP
- CUSIP Number: 00653a107
Tip: Access positions for across all investors
Analyze quarterly positions in Adaptimmune Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adaptimmune Therapeutics stock
Who bought or sold Adaptimmune Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Long Focus Capital Management | 19M | $2.4M | -22% | Sep 2025 |
|
| UBS Group | 6.7M | $867k | 10490% | Sep 2025 |
|
| Morgan Stanley | 4.2M | $1.0M | 100% | Jun 2025 |
|
| Renaissance Technologies | 4.1M | $527k | 115% | Sep 2025 |
|
| Jane Street | 2.8M | $365k | 100% | Sep 2025 |
|
| Acadian Asset Management | 1.5M | $186k | -24% | Sep 2025 |
|
| Empirical Finance | 800k | $104k | 0% | Sep 2025 |
|
| National Asset Management | 500k | $65k | 100% | Sep 2025 |
|
| Rathbones Brothers | 433k | $56k | 0% | Sep 2025 |
|
| FMR | 340k | $44k | -27% | Sep 2025 |
|
| Susquehanna International | 308k | $40k | 491% | Sep 2025 |
|
| Citadel Advisors | 281k | $37k | 100% | Sep 2025 |
|
| Lumbard Investment Counseling | 114k | $15k | 100% | Sep 2025 |
|
| Lakeridge Wealth Management | 110k | $14k | 100% | Sep 2025 |
|
| XTX Topco | 103k | $13k | 28% | Sep 2025 |
|
| State of Tennessee, Treasury Department | 73k | $9.5k | 0% | Sep 2025 |
|
| Captrust Financial Advisors | 69k | $8.9k | -13% | Sep 2025 |
|
| Geode Capital Management | 67k | $8.7k | 0% | Sep 2025 |
|
| Group One Trading | 62k | $8.0k | 100% | Sep 2025 |
|
| Sei Investments | 55k | $7.1k | 0% | Sep 2025 |
|
| State of New Jersey Common Pension Fund D | 55k | $7.1k | 0% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 53k | $6.9k | 0% | Sep 2025 |
|
| Northern Trust | 49k | $6.3k | -5% | Sep 2025 |
|
| Wealth Enhancement Advisory Services | 41k | $5.7k | 277% | Sep 2025 |
|
| BlackRock | 38k | $5.0k | -79% | Sep 2025 |
|
| Columbia Advisory Partners | 37k | $4.8k | 0% | Sep 2025 |
|
| Massey, Quick & Co | 30k | $3.9k | 0% | Sep 2025 |
|
| SG Americas Securities | 28k | $4.0k | 100% | Sep 2025 |
|
| Raymond James Financial | 25k | $3.3k | 0% | Sep 2025 |
|
| Prosperity Wealth Management | 19k | $2.5k | -3% | Sep 2025 |
|
| Intl Fcstone | 15k | $2.0k | 100% | Sep 2025 |
|
| Traynor Capital Management | 15k | $2.0k | 100% | Sep 2025 |
|
| Simplex Trading | 12k | $1.0k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 12k | $1.6k | -24% | Sep 2025 |
|
| Rockefeller Capital Management | 12k | $1.6k | 100% | Sep 2025 |
|
| IFG Advisory | 12k | $1.5k | 0% | Sep 2025 |
|
| X-Square Capital | 12k | $1.1k | 4% | Sep 2025 |
|
| Kornitzer Capital Management | 10k | $1.3k | 0% | Sep 2025 |
|
| Rhumbline Advisers | 5.7k | $744.867100 | -33% | Sep 2025 |
|
| Wells Fargo & Company | 2.7k | $351.000000 | -94% | Sep 2025 |
|
| Barclays | 2.5k | $329.926800 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 2.1k | $197.979600 | -98% | Sep 2025 |
|
| Garde Capital | 750.00 | $180.000000 | 100% | Jun 2025 |
|
| Tower Research Capital | 700.00 | $91.000000 | -94% | Sep 2025 |
|
| Bryn Mawr Trust | 604.00 | $79.003200 | 0% | Sep 2025 |
|
| HighMark Wealth Management | 287.00 | $36.994300 | 0% | Sep 2025 |
|
| Parallel Advisors | 250.00 | $33.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 213.00 | $28.009500 | 0% | Sep 2025 |
|
| Advisory Services Network | 125.00 | $16.000000 | 100% | Sep 2025 |
|
| Investors Research Corp | 100.00 | $13.000000 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 100.00 | $13.000000 | 100% | Sep 2025 |
|
| Koesten, Hirschmann & Crabtree | 47.00 | $6.998300 | 0% | Sep 2025 |
|
| TD Waterhouse Canada | 14.00 | $2.000600 | 0% | Sep 2025 |
|
| SBI Securities | 10.00 | $1.000000 | 0% | Sep 2025 |
|
| Danske Bank A/s | 1.00 | $0 | 100% | Sep 2025 |
|
Who sold out of Adaptimmune Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| EcoR1 Capital | Jun 2025 | 27M | $6.6M |
| Two Seas Capital | Jun 2025 | 23M | $5.4M |
| NEA Management Company | Jun 2025 | 17M | $4.1M |
| MPM Asset Management | Jun 2025 | 4.8M | $1.2M |
| MPM Oncology Impact Management | Jun 2025 | 4.4M | $1.1M |
| Rock Springs Capital Management | Jun 2025 | 2.5M | $595k |
| Jpmorgan Chase & Co | Mar 2025 | 882k | $174k |
| State Street Corporation | Jun 2025 | 427k | $102k |
| Key Client Fiduciary Advisors | Jun 2025 | 176k | $42k |
| Clear Harbor Asset Management | Jun 2025 | 145k | $35k |
| Almitas Capital | Jun 2025 | 109k | $26k |
| Newman Dignan & Sheerar | Jun 2025 | 28k | $6.7k |
| Stifel Financial | Jun 2025 | 23k | $5.5k |
| Wiley Bros.-aintree Capital | Jun 2025 | 20k | $4.8k |
| Baader Bank | Jun 2025 | 15k | $2.2k |
| Two Sigma Advisers | Jun 2025 | 13k | $3.2k |
| Ausdal Financial Partners | Jun 2025 | 13k | $3.0k |
| Plante Moran Financial Advisors | Jun 2025 | 925.00 | $222.000000 |
| Transce3nd | Jun 2025 | 175.00 | $42.000000 |
| Northwestern Mutual Wealth Management Company | Jun 2025 | 153.00 | $36.995400 |